KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Current Assets (2018 - 2025)

ClearPoint Neuro's Current Assets history spans 13 years, with the latest figure at $51.3 million for Q3 2025.

  • For Q3 2025, Current Assets rose 49.52% year-over-year to $51.3 million; the TTM value through Sep 2025 reached $51.3 million, up 49.52%, while the annual FY2024 figure was $33.4 million, 7.77% down from the prior year.
  • Current Assets for Q3 2025 was $51.3 million at ClearPoint Neuro, down from $54.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $70.4 million in Q1 2021 and bottomed at $24.2 million in Q1 2025.
  • The 5-year median for Current Assets is $51.2 million (2022), against an average of $49.3 million.
  • The largest annual shift saw Current Assets skyrocketed 222.85% in 2021 before it crashed 49.1% in 2025.
  • A 5-year view of Current Assets shows it stood at $61.9 million in 2021, then dropped by 17.31% to $51.2 million in 2022, then dropped by 29.32% to $36.2 million in 2023, then fell by 7.77% to $33.4 million in 2024, then skyrocketed by 53.85% to $51.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Current Assets are $51.3 million (Q3 2025), $54.0 million (Q2 2025), and $24.2 million (Q1 2025).